COMPANY

About us

AbCheck provides a unique source of therapeutic antibodies with one of the industry’s most versatile technology platforms. We provide high-quality drug candidates through discovery collaborations or strategic research partnerships based on flexible business terms including royalty-free agreements.

We generate target specific human antibody domains which can be used in distinct therapeutic formats.

AbCheck was founded in 2009 and is a spin-out of Affimed’s technology discovery platform. AbCheck is a wholly owned subsidiary of Affimed GmbH, a biopharmaceutical company developing highly targeted cancer immunotherapies.

WHO WE ARE

Our Management

Dr. Volker Lang
MANAGING
DIRECTOR

Dr. Volker
Lang

Dr. Vera Molkenthin
CHIEF
SCIENTIST

Dr. Vera
Molkenthin

Dr. Oleh Petriv
VP NEW TECHNOLOGY
DEVELOPMENT

Dr. Oleh
Petriv

Bc. Shelly Adams
VP BUSINESS
DEVELOPMENT

Bc. Shelly
Adams

WHO WE ARE

Our Team

We are a highly skilled and experienced team operating transparently and in agreement with the highest ethical and corporate governance standards – mutual respect, integrity and trust are our foundation.

AbCheck fosters a close, collaborative working relationship with our clients. Our experience has demonstrated that this type of close interaction is very valuable in the development of successful projects. We insist on the highest quality standard, challenge conventional thinking within our team and cultivate rigorous problem solving, resulting in best solutions and scientific innovations that help to deliver optimal results in a timely fashion.

25+
PEOPLE IN 4 TEAMS
75+
COFFEES PER DAY
Msc. Dominik
Hinz
Head of Phage
Display
Dr. Peter
Milovník
Head of Antibody Engineering
Dr. Michael
Tomaszowski
Head of Yeast
Display
Dr. Yuriy
Rzhepetskyy
Cell Biologist
Dr. Ahmad
Trad
Head of Cell
Culture
LET’S DISCOVER MORE

Partnering

Discover sophisticated
solutions with us!

Careers

Do you want to join us?

Our Services

Antibody
Discovery

Services

Antibody
Optimization

Services

Our Unique Platforms

Proprietary
Libraries

Technologies

Rabbit Mass
Humanization

Technologies

AbSieve™
Antibody
Selection

Technologies

AbAccel™
Antibody
Optimization

Technologies